Lyell Immunopharma (LYEL) Other Gross PP&E Adjustments (2020 - 2025)
Historic Other Gross PP&E Adjustments for Lyell Immunopharma (LYEL) over the last 6 years, with Q3 2025 value amounting to -$19.9 million.
- Lyell Immunopharma's Other Gross PP&E Adjustments rose 4568.76% to -$19.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$19.9 million, marking a year-over-year increase of 4568.76%. This contributed to the annual value of $84.1 million for FY2024, which is 1865.68% down from last year.
- According to the latest figures from Q3 2025, Lyell Immunopharma's Other Gross PP&E Adjustments is -$19.9 million, which was up 4568.76% from -$21.0 million recorded in Q2 2025.
- In the past 5 years, Lyell Immunopharma's Other Gross PP&E Adjustments ranged from a high of $104.7 million in Q4 2022 and a low of -$48.4 million during Q2 2021
- In the last 5 years, Lyell Immunopharma's Other Gross PP&E Adjustments had a median value of -$38.2 million in 2024 and averaged -$8.6 million.
- As far as peak fluctuations go, Lyell Immunopharma's Other Gross PP&E Adjustments skyrocketed by 18433.45% in 2021, and later plummeted by 1865.68% in 2024.
- Lyell Immunopharma's Other Gross PP&E Adjustments (Quarter) stood at $85.2 million in 2021, then grew by 22.88% to $104.7 million in 2022, then dropped by 1.24% to $103.4 million in 2023, then decreased by 18.66% to $84.1 million in 2024, then tumbled by 123.68% to -$19.9 million in 2025.
- Its last three reported values are -$19.9 million in Q3 2025, -$21.0 million for Q2 2025, and -$23.6 million during Q1 2025.